ALK and neoplasm: In addition, in our study, liquid biopsy was able to highlight 26 mutations, with the prevalence of the ALK mutation in 96.6% of patients, supporting the idea that this approach could be an effective tool in cases with insufficient tumor tissue specimens or in cases where tissue specimens are not obtainable.